Heart valve disease

Programme-HeartValve

Our heart valve disease programme contains ten modules designed to cover all aspects of the condition, from its epidemiology and pathology through to the latest advances in diagnosis and treatment. The programme – endorsed by the British Heart Valve Society – leads to nine continuing professional development (CPD) credits, which have been accredited by the European Board of Accreditation in Cardiology.

The programme has been made available with an educational grant from Edwards Lifesciences. It has been independently written by leading international experts in the field.

Professor John Chambers, St Thomas’ Hospital, London (programme editor)
Dr Paul Aifesehi, Mount Sinai Medical Center, New York, USA
Dr Joanna Chikwe, Mount Sinai Medical Center, New York, USA
Dr Sean Coffey, Cardiology Research Group, Department of Medicine, University of Otago
Dr Joanna d’Arcy, John Radcliffe Hospital, Oxford
Dr Marc R Dweck, University of Edinburgh and Edinburgh Heart Centre
Dr Russell J Everett, University of Edinburgh and Edinburgh Heart Centre
Dr Rajdeep Khattar, Royal Brompton Hospital, London
Dr Jacob Kriegel, Colombia Presbyterian College of Physicians and Surgeons, New York, USA
Dr Pu-Lin Luo, St George’s, University of London
Professor David E Newby, University of Edinburgh and Edinburgh Heart Centre
Mrs Denise Park, St Thomas’ Hospital, London
Dr Bernard D Prendergast, Guy’s and St Thomas’s NHS Trust, London
Dr Ronak Rajani, St Thomas’ Hospital, London
Dr Marzia Rigolli, John Radcliffe Hospital, Oxford
Dr Jonathan Sandoe, Leeds Teaching Hospitals NHS Trust, Leeds
Dr Stephen Spindel, Mount Sinai Medical Center, New York, USA
Dr Louise Tillyer, Royal Brompton Hospital, London (now retired)

Heart valve disease module 1: epidemiology

Released 1 March 2016   Programme: Heart valve disease 1 CPD/CME credit

Heart valve disease module 1: epidemiology
  • Understand the temporal and geographical trends in valve disease
  • Understand the prevalence and incidence of valve disease
  • Understand the causes of valve disease by position
  • Be aware of variations in access to care

Heart valve disease module 2: pathophysiology

Released 1 March 2016   Programme: Heart valve disease 1 CPD/CME credit

Heart valve disease module 2: pathophysiology
  • Understand the basic structure of cardiac valves
  • Understand the pathophysiology underlying the most common heart valve disorders including: - degenerative heart valve disease - myxomatous heart valve degeneration - rheumatic heart disease - functional heart valve disease - endocarditis - systemic inflammatory diseases
  • Discuss novel therapeutic strategies and how these might relate to the underlying pathophysiology

Heart valve disease module 3: disease presentation

Released 1 March 2016   Programme: Heart valve disease 1 CPD/CME credit

Heart valve disease module 3: disease presentation
  • Appreciate the variable and unpredictable natural history of valve lesions
  • Recognise common symptoms of the individual valve lesions
  • Be aware of physical signs commonly associated with valve lesions .

Heart valve disease module 4: diagnosis

Released 1 March 2016   Programme: Heart valve disease 1 CPD/CME credit

Heart valve disease module 4: diagnosis
  • Understand the routine echocardiographic methods of quantifying valve disease
  • Appreciate the additional information obtained from advanced echocardiographic techniques including stress and 3D
  • Understand the complementary roles of computed tomography and cardiac magnetic imaging
  • Recognise the cut-off values for grading valve disease
  • Understand how imaging relates to criteria for surgical intervention

Heart valve disease module 5: medical therapies for treatment of valvular heart disease

Released 1 March 2016   Programme: Heart valve disease 1 CPD/CME credit

Heart valve disease module 5: medical therapies for treatment of valvular heart disease
  • Understand the role of disease-modifying pharmacotherapy in valvular heart disease (VHD)
  • Understand the role of supportive pharmacotherapy in VHD
  • Recognise the indications for anticoagulation in VHD
  • Be aware of the patient groups at high risk of developing infective endocarditis
  • Realise the reasons for recent changes in international guidelines which restrict antibiotic prophylaxis of endocarditis
  • Compare and contrast the differing recommendations for antibiotic prophylaxis of the European Society of Cardiology and the UK National Institute for Health and Clinical Excellence

Heart valve disease module 6: organisation of care for valve disease

Released 1 March 2016   Programme: Heart valve disease 0.5 CPD/CME credits

Heart valve disease module 6: organisation of care for valve disease
  • Be aware of the limitations of detection
  • Recognise the limitations in current surveillance systems
  • Understand the limitations in non-specialist surgical centres
  • Discuss the advantages of a specialist valve clinic

Heart valve disease module 7: anti-thrombotic therapy for valvular heart disease

Released 1 March 2016   Programme: Heart valve disease 1 CPD/CME credit

Heart valve disease module 7: anti-thrombotic therapy for valvular heart disease
  • Introduce anticoagulation options in patients with native or prosthetic heart valves
  • Review early antithrombotic therapy after valve surgery
  • Understand the challenges of interrupting anticoagulation in valve patients
  • Review anticoagulation options during pregnancy

Heart valve disease module 8: endocarditis

Released 1 March 2016   Programme: Heart valve disease 1 CPD/CME credit

Heart valve disease module 8: endocarditis
  • Understand when infective endocarditis should be suspected
  • Understand the criteria for diagnosis
  • Understand the principles of management
  • Understand the criteria for surgery.

Heart valve disease module 9: surgery for heart valve disease

Released 1 March 2016   Programme: Heart valve disease 1 CPD/CME credit

Heart valve disease module 9: surgery for heart valve disease
  • Recognise the indications for surgery with impaired LV function
  • Know the indications for surgery in asymptomatic disease
  • Understand the indications for surgery at the time of coexistent CABG

Heart valve disease module 10: transcatheter valve treatment and other future developments

Released 1 March 2016   Programme: Heart valve disease 1 CPD/CME credit

Heart valve disease module 10: transcatheter valve treatment and other future developments
  • Understand transcatheter approaches to the mitral and aortic valves
  • Know patient selection for aortic valve devices
  • Understand delivery approaches for replacement valves
  • Recognise potential complications in such a procedure
  • Understand mitral valve techniques